Acute bile duct ligation ameliorates ischemic renal failure

Nephron

Volumn 95, Issue 2, 2003, Pages

  Jeyarajah, D Rohan ^a   Kielar, Mariusz L ^a   Zhou, Xin J ^a   Zhang, Ying ^a   Lu, Christopher Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Biliary obstruction; Interleukin 1 receptor antagonist; Interleukin 10

Indexed keywords

CREATININE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; LIVER PROTEIN; MESSENGER RNA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CHOLESTASIS; COMMON BILE DUCT; CREATININE; DISEASE MODELS, ANIMAL; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; LIGATION; LIVER; MALE; MICE; MICE, INBRED C3H; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-10; RNA, MESSENGER;

EID: 0345258422     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073677     Document Type: Article

References (42)

1. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, Rabb H: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001;108:1283-1290.
2. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996;97:1056-1063.
3. Deng J, Hu X, Hewitt S, Star RA: Alpha melanocyte stimulating hormone (MSH) inhibits renal injury following cisplatin administration, in part, via interleukin 10 (abstract). J Am Soc Nephrol 2001;12:A4184.
4. Daemen MARC, van de Ven MWCM, Heineman E, Buurman WA: Involvement of endogenous interleukin-10 and tumor necrosis factor-a in renal ischemia-reperfusion injury. Transplantation 1999;67:792-800.
5. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH: Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001;104:1308-1313.
6. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ: Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 2001;21:5528-5534.
7. Nesic O, Xu GY, McAdoo D, High KW, Hulsebosch C, Perez-Pol R: IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma 2001;18:947-956.
8. Donnahoo KK, Shames BD, Harken AH, Meldrum DR: Review article: The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999;162:196-203.
9. Meldrum KK, Meldrum DR, Hile KL, Yerkes EB, Ayala A, Cain MP, Rink RC, Casale AJ, Kaefer MA: p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 2001;281:C563-C570.
10. Kielar ML, Rohan JD, Lu CY: The regulation of ischemic acute renal failure by extrarenal organs. Curr Opin Nephrol Hypertens 2002;11:451-457.
11. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation (review; 64 refs). N Engl J Med 1999;340:448-454.
12. Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA: Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 2001;60:1047-1057.
13. Green J, Better OS: Systemic hypotension and renal failure in obstructive jaundice-mechanistic and therapeutic aspects. J Am Soc Nephrol 1995;5:1853-1871.
14. Bomzon L, Weinbroum A, Kamenetz L: Systemic hypotension and pressor responsiveness in cholestasis: a study in conscious 3-day bile duct ligated rats. J Hepatol 1990:11:70-76.
15. Yarger WE: Intrarenal mechanism of salt retention after bile duct ligation in rats. J Clin Invest 1976;57:408-418.
16. Beierle EA, Vauthey JN, Moldawer LL, Copeland EM: III. Hepatic tumor necrosis factor alpha production and distant organ dysfunction in a murine model of obstructive jaundice. Am J Surg 1996;171:202-206.
17. Plebani M, Panozzo MP, Basso D, De Paoli M, Biasin R, Infantolino D: Cytokines and the progression of liver damage in experimental bile duct ligation. Clin Exp Pharmacol Physiol 1999;26:358-363.
18. Baum M, Stirling GA, Dawson JL: Further study into obstructive jaundice and ischaemic renal damage. Br Med J 1969;ii:229-231.
19. Aoyagi T, Lowenstein LM: The effect of bile acids and renal ischemia on renal function. J Lab Clin Med 1968;71:686-692.
20. Tajiri K, Miyakawa H, Liu J, Kamiyama T, Marumo F, Sato C: Enhanced renal susceptibility to ischemia-reperfusion injury in the rat with obstructive jaundice. Hepatogastroenterology 1997;44:789-795.
21. Burne MJ, Haq M, Matsuse H, Mohapatra S, Rabb H: Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model. Transplantation 2000;69:1023-1025.
22. Dinarello CA: The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 2000;343:732-734.
23. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML: Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol 1998;30:2567-2576.
24. Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol 1999;277:L919-L923.
25. Huber TS, Gaines GC, Welborn MB, Rosenberg JJ, Seeger JM, Moldawer LL: Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 2000;13:425-434.
26. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML: IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 2000;165:2798-2808.
27. Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J: Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108:1917-1922.
28. Yang Z, Zingarelli B, Szabo C: Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000;101:1019-1026.
29. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RCJ, Harken AH: Therapeutic implications of interleukin-10 in surgical disease. Shock 1998;10:309-318.
30. Engles RE, Huber TS, Zander DS, Hess PJ, Welborn MB, Moldawer LL, Seeger JM: Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J Surg Res 1997;69:425-428.
31. Spera PA, Ellison JA, Feuerstein GZ, Barone FC: IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998;251:189-192.
32. Eppinger MJ, Ward PA, Bolling SF, Deeb GM: Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 1996;112:1301-1305;discussion 1305-1306.
33. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, Star RA: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001;60:2118-2128.
34. Haq M, Norman J, Saba SR, Ramirez G, Rabb H: Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998:9:614-619.
35. Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ: Conclusive evidence of endotoxaemia in biliary obstruction. Gut 1998;42:293-299.
36. Van Bossuyt H, Desmaretz C, Gaeta GB, Wisse E: The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J Hepatol 1990;10:274-279.
37. Melnikov VY, Schrier RW, Edelstein CL: Role of interleukin-18 (IL-18) in endotoxemia-induced acute renal failure (ARF) (abstract). J Am Soc Nephrol 2001;12:A4116.
38. Bailey ME: Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976;63:774-778.
39. Daemen MA, Heemskerk VH, van't Veer C, Denecker G, Wolfs TG, Vandenabeele P, Buurman WA: Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/ reperfusion injury by preventing apoptosis and inflammation. Circulation 2000;19;102:1420-1426.
40. Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, Ambiru S, Shimizu H, Nakagawa K: Plasma human hepatocyte growth factor concentrations in patients with biliary obstruction. J Gastroenterol Hepatol 2000;15:76-82.
41. Matsumoto K, Nakamura T: Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001;59:2023-2038.
42. Liu Y: Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 2002;11:23-30.